Fulcrum Therapeutics
FULC
#8222
Rank
โ‚ฌ0.16 B
Marketcap
2,98ย โ‚ฌ
Share price
4.38%
Change (1 day)
-25.89%
Change (1 year)

EPS for Fulcrum Therapeutics (FULC)

EPS in 2023 (TTM): -1,71ย โ‚ฌ

According to Fulcrum Therapeutics's latest financial reports the company's current EPS (TTM) is -1,73ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -2,38ย โ‚ฌ a decrease over its 2021 EPS that were of -2,20ย โ‚ฌ.

EPS history for Fulcrum Therapeutics from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-1,71ย โ‚ฌ-28.24%
2022-2,38ย โ‚ฌ8.3%
2021-2,20ย โ‚ฌ-18.51%
2020-2,70ย โ‚ฌ-31.36%
2019-3,94ย โ‚ฌ77.16%
2018-2,22ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-2,10ย โ‚ฌ 21.11%๐Ÿ‡บ๐Ÿ‡ธ USA